Clinical Trials Logo

Deafness clinical trials

View clinical trials related to Deafness.

Filter by:

NCT ID: NCT04469946 Completed - Hearing Impairment Clinical Trials

Hearing Aid Noise Reduction in Pediatric Users Pilot Study (Oticon Pilot Study)

Start date: March 5, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the efficacy of OpenSound Navigator (OSN), a hearing aid speech-enhancement algorithm developed by Oticon, as treatment for pediatric hearing aid users. The study used a within-subjects design with pre- and post-comparisons involving fifteen pediatric (ages 6-12) patients with symmetrical sensorineural hearing losses ranging from the mild to moderately-severe degree. All participants were fit with bilateral Oticon OPN™ behind-the-ear hearing aids set with the OSN algorithm enabled. The investigators evaluated hearing aid benefit through word recognition in noise (behavioral testing) and everyday hearing/listening abilities (parental/legal guardian reported) within one week of the hearing aid fitting (pre-intervention) and two months post fitting (post-intervention).

NCT ID: NCT04462198 Completed - Clinical trials for Sensorineural Hearing Loss

Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss

Start date: October 15, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

This is a randomized, double-blind study of PIPE-505, or placebo, in subjects with hearing loss associated with speech-in-noise impairment.

NCT ID: NCT04454255 Completed - Hearing Loss Clinical Trials

Benefits of Tablet-based Serious Games to Promote Speech Production in Young Children With Hearing Disabilities

FunSpeech
Start date: March 1, 2020
Phase: N/A
Study type: Interventional

Learning to speak is a major challenge for children with hearing impairments. Nowadays, special devices such as conventional hearing aids, bone-anchored hearing aids (BAHA) or cochlear implants (CI) allow successful rehabilitation of patients with hearing disabilities. To obtain maximum benefit from these technical aids, instrumented hearing impaired children require specific and intensive speech therapy to compensate for speech development delays. In addition, it is also of primary importance that during daily life (e.g., at home, at school) children are provided with sufficient and good quality auditory stimulation. The main goal of this project is to encourage speech production with an edutainment tool that can be used at home and that is adapted to the specific needs of young hearing impaired children. For this purpose, the investigators have recently designed an innovative educational solution: FunSpeech, a tablet-based set of video games that respond exclusively to sound and speech. The aim of this serious game is to encourage hearing impaired children to produce controlled sounds in terms of rhythm, intensity, and pitch. These are the main abilities required for controlled speech production. Finally, this serious game aims to support the parents' key role in the speech learning process by offering an effective solution that is easy to use at home with young children.

NCT ID: NCT04450290 Completed - Clinical trials for Hearing Loss, Sensorineural

Dexamethasone-Eluting Cochlear Implant Electrode

CIDEX
Start date: June 30, 2020
Phase: N/A
Study type: Interventional

A newly developed MED-EL Cochlear Implant incorporates the anti-inflammatory agent dexamethasone (DEX) into the electrode array. The passive elution of DEX during the post-implantation period has the purpose of counteracting the increase of the post-operative impedance induced by the insertion trauma. The aim of this clinical investigation is to obtain a first experience in use of the investigational device in the adult clinical population, and to initially assess tools, techniques and performance outcome measures that may be considered in future clinical studies of similar devices.

NCT ID: NCT04427033 Completed - Hearing Loss Clinical Trials

The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study

Start date: December 6, 2019
Phase:
Study type: Observational

The Bonebridge system using the BCI 601 is marketed since 2012. Previous prospective, multi-center, non-randomized studies on the BCI 601 Bonebridge performed in adult and paediatric populations have shown a significant improvement in terms of aided sound field (SF) thresholds, word recognition scores (WRS), speech reception thresholds (SRT) and subjective device satisfaction. Safety was established by stable residual hearing and low complication rates. The Bonebridge, implanted in over 600 clinics worldwide, is the world's first active transcutaneous bone conduction implant (BCI) system. This study now focuses on the further developed BCI 602 (marketed since 2019) that has the same indication criteria and performance characteristics. The aim of this post-market clinical follow-up (PMCF) study is to provide clinical data for the long-term performance and safety when implanted with the Bonebridge BCI 602 .

NCT ID: NCT04413084 Completed - Clinical trials for HEARING IMPAIRED CHILDREN

Vestibular Rehabilitation for Dizziness in Hearing Impaired Children.

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

There is a need to manage dizziness in vestibular dysfunction patients with the vestibular rehabilitation to improve the life style of these patients. Vestibular rehabilitation exercises are beneficial for the vestibular dysfunction patients because they decrease dizziness and visual symptoms, increase walking and balance functions and with this the general activity level also increases. In my study my goal is to apply two different vestibular exercise and check their effects on dizziness in hearing impaired children's.

NCT ID: NCT04367961 Completed - Deafness Clinical Trials

Auditory Profile and Language Development in Children Operated for Cleft Palate

VELAUDI
Start date: March 11, 2020
Phase:
Study type: Observational

Observational study about children with cleft palate from surgery to pre-adolescence :Description of language development and hearing profile.

NCT ID: NCT04331015 Completed - Clinical trials for Sensorineural Hearing Loss

Artificial Intelligence in Diagnosis of DFNA9

DFNA9
Start date: February 1, 2020
Phase:
Study type: Observational

To study the positive predictive value of Audiogene v.4.0 open source online machine learning tool in accurately predicting DFNA9 (DeaFNess autosomal dominant ninth) as top 3 gene loci in a large series of genetically confirmed c.151C>T,p.Pro51Ser (p.P51S) variant carriers in COCH (coagulation factor C Homology).

NCT ID: NCT04320407 Completed - Clinical trials for Conductive Hearing Loss

Osia CPT Code Study

Start date: September 30, 2020
Phase: N/A
Study type: Interventional

To evaluate the clinical efficacy of the Osia 2 system in patients with conductive or mixed conductive hearing loss in a US cohort.

NCT ID: NCT04291274 Completed - Clinical trials for Long Term Neurobehavioral Effects

The Neurobehavioral Effects of Anesthetics on Infants With Hearing Impairment(Retrospective Research)

Start date: November 1, 2019
Phase:
Study type: Observational

The long-term effect of general anesthesia on developing brain is the focus of clinicians when infants exposed to general anesthesia for a long time during operation. A retrospective study showed that children exposed to long-term or repeated operations, the anesthetics had a higher incidence of cognitive impairment in adolescence than those did no. When infants with hearing impairment undergo bilateral cochlear implant surgery, they are at high risk of long-term neurobehavioral abnormalities caused by anesthesia. In this study, investigators intend to observe the long-term behavioral abnormalities of hearing-impaired infants after intravenous or inhalation anesthesia by a ambispective cohort study.